LIFESAVER News
News
LIFESAVER FINAL EVENT RECAP
The LIFESAVER final event gathered experts, policymakers, and innovators to celebrate breakthrough achievements in maternal health research, showcasing Europe’s leadership in ethical science, cross-sector collaboration, and evidence-based innovation for safer pregnancies.
LIFESAVER FINAL FILM
The film showcases LIFESAVER’s breakthrough bio-digital placenta, combining in vitro and in silico science to predict fetal drug exposure, accelerate approvals, reduce R&D delays, and redefine safe, data-driven innovation in maternal-fetal health. Click here!
Microfluidic Breakthrough Enhances Cell Culture Sampling
LIFESAVER consortium partners, Microfluidics Innovation Center and I3S, introduce a cutting-edge microfluidic fraction collector, revolutionizing automated sample collection in cell culture studies. Click here!
UCSC/CREM PUBLISHES Paper: Advancing Understanding of the Fetal-Maternal Interface in Early Pregnancy
On July 31 2024, UCSC/CREM published the paper “Unveiling the Human Fetal-Maternal Interface During the First Trimester.” The study reviews placental structures, fluid dynamics, and research challenges, emphasizing advanced models to enhance understanding of pregnancy biomechanics.
ALTERNATIVE & LIFESAVER Workshop: Regulatory Innovation and Health Safety
ALTERNATIVE & LIFESAVER talk about innovations in cardiotoxicity detection, fetal health risk assessments, regulatory advancements, and collaborative opportunities for enhancing healthcare safety. Watch the October 23, 2024, session now!
Project Insights Unveiled
Don’t miss Thomas Zadrozny’s enlightening update on the LIFESAVER Project. His insights into our latest innovations offer a glimpse into the impactful work ahead. Watch the full interview for more details! Click here
i3S publishes 2nd paper: Enhancing Electrochemical Sensors for Remote Sensing Applications
On April 30, i3S published the paper ”Multi‐Parametric Decision System for Analytical Performance Assessment of Electrochemical (Bio)Sensors‘. The study improves electrode treatments to increase the accuracy and reproducibility essential for advanced sensor applications.
i3S publishes paper: AptaShield, Revolutionizing Point-of-Care with Universal Biosensing Technology
On April 15, 2024, LIFESAVER partner i3S published paper ‘AptaShield, revolutionizing optical molecular biosensing‘. This technology simplifies biosensor customization for diverse analytes, ensuring rapid, selective, and reliable detections, making it ideal for point-of-care applications.
INRIM publishes paper on Standardized Protocols for Resazurin-Based Viability Assays
On March 25, 2024, LIFESAVER partner INRIM published the paper ‘Standard operating procedure to optimize resazurin-based viability assays‘. This paper standardizes procedures to enhance the reliability of cytotoxicity studies crucial in drug screening and safety assessments, targeting less than 20% measurement imprecision.
Joining forces to improve maternal health & pregnancy pharmacovigilance: ConcePTION & LifeSaver
Webinar recording now available: ConcePTION and LIFESAVER discussed filling knowledge gaps in medicine safety during pregnancy and breastfeeding, and advancing risk assessment for drugs in a joint webinar held on May 14, 2024.
LifeSaver Technology Transfer Workshops, 11th and 14th of June 2024 | Porto, Portugal
On June 11th and 14th, the LIFESAVER project will host workshops at i3S, Porto, focusing on advancing technology transfer in healthcare. These sessions will cover regulatory frameworks, commercialization strategies, and investor engagement to facilitate the translation of research into clinical solutions. Register here: [i3S Workshops]
LIFESAVER M30 GENERAL ASSEMBLY & international CONFERENCE, PORTUGAL, JUNE 2024
LIFESAVER’s International Conference, hosted by i3S in Porto, was held on June 13, 2024. Experts discussed challenges and innovations in maternal-fetal healthcare, fostering impactful collaborations.
CONCEPTION & LIFESAVER – Joining forces to improve maternal health & pregnancy pharmacovigilance
ConcePTION and LIFESAVER are collaborating to enhance pharmacovigilance in pregnancy and breastfeeding. ConcePTION has developed an ecosystem over five years, while LIFESAVER is advancing drug and chemical risk assessment. Join our webinar on May 14 2024 to explore how our efforts complement each other. [Click here]
LIFESAVER M24 GENERAL ASSEMBLY MEETING 2023
The LIFESAVER Project consortium partners recently convened in Malta on the 21st November 2023 for the 24-month General Assembly Meeting. The meeting was preceded by a tour of Malta Life Sciences Park
Lifesaver PRESS STATEMENT: CONFERENCE HELD THURSDAY, 22 NOVEMBER 2023 IN MALTA
The Malta Innovation Hub at the Malta Life Sciences Park hosted the other partners of the LIFESAVER Horizon funded project.
Digital Placenta On-a-chip: Malta is partnering in EU funded research to help pregnant women minimise risks to the foetus from potentially harmful chemical and medicinal products.
Press Release
Lifesaver CONFERENCE ON THURSDAY, 22 NOVEMBER 2023 IN MALTA
Join us for the LifeSaver conference in Malta. It aims to foster regulatory science in tackling combined exposures to industrial chemicals and pharmaceuticals, advancing from scientific research to evidence-based policies. Registration is now open!
Lifesaver TECHNOLOGY STARTUP TRAINING WORKSHOP IN MALTA – 23 NOVEMBER 2023
Join us for the LifeSaver Technology Startup Training Workshop on Thursday, 23rd November 2023 in Malta from 09:00 – 14:30. The training will cover the following: 1) Always equate product features with tangible benefits 2) Understand how to position the product in the market by using technical jargon precisely and only when appropriate 3) Back your calculated ROI with sufficient data 4) Explain how you will implement a smooth product transition process and explain how end-users will be provided support during and after on-boarding 5) Identify prospect’s biggest bottlenecks and demonstrate how you can address them. Registration is now open!
Lifesaver PRESENTS ITS PROJECT AT INL OPEN DAY, 30 September, 2023
Our partner, INL, hosted its third open-day event in Braga, Portugal, to celebrate science with engaging activities suitable for all ages. More than 1000 attendees had the opportunity to connect with the world of science and explore INL’s ‘Nanoworld.’
During the event, Andrea Cruz, an INL Staff Researcher, introduced LifeSaver to the public, showcasing the technology alongside a LifeSaver video demonstration.
Lifesaver PRESENTS ‘TISSUE DISSOCIATION & AND THE ESTABLISHMENT OF PRIMARY HUMAN CELL CULTURES’ WEBINAR, 20 September, 2023
LifeSaver Project presented a free training event on ‘Tissue dissociation & and the establishment of primary human cell cultures’, hosted by EVERCYTE .
Speakers Regina Grillari & Matthias Wieser from EVERCYTE GmbH are cell biologists with more than 20 years’ experience in isolating cells from different human tissues for setting up of in vitro test systems & cell factories.
Lifesaver attends the JOINT POLICY SESSION OF THE GREEN DEAL PROJECTS, 11 September, 2023
The LIFESAVER project was represented by our Coordinator, Enginsoft, by Carla Baldasso at the Joint Policy Session of the Green Deal Projects.
Lifesaver & elvesys attends MPS world summit, Berlin, 26-30 june, 2023
The LIFESAVER project and Elvesys Microfluidic Innovation Center’s fluidic demonstrator were displayed at our booth at the MPS. (Also proudly representing our GreenDeal Cluster sister project ALTERNATIVE)
Lifesaver M18 MIDTERM REVIEW MEETING 2023
The LIFESAVER Project consortium partners recently convened at INL in Braga, Portugal, from 12 -16th of July 2023 for the 18-month Review Meeting. The meeting included a tour of INL laboratory facilities and the unveiling of the Digital Placenta that the partners have been working on for the past 18 months.
Lifesaver Good Cell Culture Practice Webinar
The LifeSaver Project invites you to our upcoming training event on Good Cell Culture Practice.
Register now for our FREE ‘Good Cell Culture Practice’ training event on Wednesday, 24th May, from 11.00 – 13.00 CEST.
https://www.eventbrite.com/e/lifesaver-webinar-good-cell-culture-practice-tickets-625081223767
Lecturer: Regina Grillari, Evercyte GmbH; cell biologist with more than 20 years experience in isolating cells from different human tissues for setting up of in vitro test systems and cell factories.
Evercyte is a biotech company based in Vienna, Austria, that specializes in the development, manufacturing, and distribution of immortalized human cells for drug discovery, toxicity testing, and cell-based assays. Their portfolio includes various cell lines, such as kidney, lung, and skin cells, and they also offer custom cell line development services.
Lifesaver AGM 2022
The LifeSaver Consortium of partners gathered in Rome on the 24th & 25th of November for the first annual AGM. The event saw all the partners from across the EU joining together for 2 days to share results, get to know one another better and workshop ideas. The event was chaired by Project Coordinator, Carla Baldasso from EngineSoft and was held at the Marriott Hotel in Rome.
The International Conference: “Clinical Translation of Perinatal Derivatives: Where Do We Stand?”
The International Conference “Clinical Translation of Perinatal Derivatives: Where Do We Stand?” was held on September 2- 3, 2022 at the Paolo VI Convention Center in Brescia, Italy. The conference was organized by Prof. Ornella Parolini and her team at the Centro di Ricerca Eugenia Menni (CREM)-Fondazione Poliambulanza. Members of the “International Placenta Stem Cell Society – IPLASS” and participants of the COST SPRINT Action attended. Numerous guests from many different countries (Austria, Belgium, Brazil, Finland, France, Germany, Ireland, Israel, United Kingdom, Spain, Sweden, Switzerland, USA) presented the latest developments in basic and clinical research with human placenta-derived stem cells.
(APRIL 2022) – ELVESYS AT MICROPHYSIO
Our consortium partner Elvesys was at the MicroPhysio workshop from 11th – 15th of April, at the beautiful Institute of Scientific Studies of Cargèse, Corsica.
“It was a pleasure to attend such inspiring talks and be able to exchange ideas with amazing scientists on the topics of organoids and organs-on-chip. These systems flow nutrients over cells grown in a chamber usually no bigger than a coin. Monitoring the level of dissolved gases will be a big step forward to making better micro-scale models of tissues in the lab.”
The LifeSaver Podcast
The LifeSaver concept is based on an original idea of hybridization of several innovative technologies, integrating digital in silico/in vitro (biodigital twin) systems, enabling the effective screening of chemicals and pharmaceuticals which might affect pregnant women’s health, and reducing animal, preclinical and clinical testing, which is not presently possible with any other existing approaches to the same level of confidence. This podcast show highlights aspects of the project and related topics.
